Answers are grounded in this paper and cite their sources.
A novel series of aryl sulfonate derivatives (4a–h) was designed, synthesized, and evaluated for potential multifunctional biological activity. Synthesis was achieved in three steps from salicylaldehyde via Schiff base formation, NaBH4 reduction, and O-sulfonation with tosyl/benzenesulfonyl chloride. Structures were confirmed by FT-IR,1H/1³C NMR, and HRMS. Molecular docking revealed strong binding affinities for human carbonic anhydrase II and tumor-associated XII, with several compounds outperforming native ligands. Antioxidant activity (DPPH assay) was highest for compound 4a (75.90% inhibition at 125 µg/mL, vs. BHT 76.34%). Anticancer evaluation (MTT assay) showed 4e as the most potent against A2780 ovarian cells (IC50 = 22.01 µM) and 4c against LNCaP prostate cells (IC50 = 59.26 µM). Structure–activity relationships indicate that electronic and lipophilic properties of substituents modulate activity. These aryl sulfonates represent promising scaffolds for further optimization as CA inhibitors with antioxidant and anticancer properties.
No takes yet. Share an insight, caveat, or question.
Bouraoui et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: